Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain

被引：40
作者：
Schkeryantz, Jeffrey M. [1 ]
Kingston, Ann E. [1 ]
Johnson, Michael P. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 11期
关键词：
D O I：
10.1021/jm060950g
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：2563 / 2568
页数：6
相关论文
共 55 条
[1]  
AMBLER SJ, 2001, Patent No. 2001032632
[2]   A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates [J].
Annoura, H ;
Fukunaga, A ;
Uesugi, M ;
Tatsuoka, T ;
Horikawa, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) :763-766
[3]  
BINGGELI A, 2002, Patent No. 2002051418
[4]   Group I metabotropic glutamate receptors: Implications for brain diseases [J].
Bordi, F ;
Ugolini, A .
PROGRESS IN NEUROBIOLOGY, 1999, 59 (01) :55-79
[5]   BAY36-7620:: A potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. [J].
Carroll, FY ;
Stolle, A ;
Beart, PM ;
Voerste, A ;
Brabet, I ;
Mauler, F ;
Joly, C ;
Antonicek, H ;
Bockaert, J ;
Müller, T ;
Pin, JP ;
Prézau, L .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :965-973
[6]  
Chen Y, 2000, NEUROSCIENCE, V95, P787
[7]  
Clark B. P., 2000, UK Patent, Patent No. [WO 2000026199, 2000026199]
[8]   (+)-2-methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors [J].
Clark, BP ;
Baker, SR ;
Goldsworthy, J ;
Harris, JR ;
Kingston, AE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) :2777-2780
[9]   CONTRIBUTION OF CENTRAL NEUROPLASTICITY TO PATHOLOGICAL PAIN - REVIEW OF CLINICAL AND EXPERIMENTAL-EVIDENCE [J].
CODERRE, TJ ;
KATZ, J ;
VACCARINO, AL ;
MELZACK, R .
PAIN, 1993, 52 (03) :259-285
[10]  
CONSTANTINO G, 2001, BIOORGAN MED CHEM, V9, P221
123456